Literature DB >> 14283428

OCULAR MANIFESTATIONS OF XERODERMA PIGMENTOSUM.

H EL-HEFNAWI, A MORTADA.   

Abstract

Keywords:  ADOLESCENCE; CHILD; CONSANGUINITY; DIATHERMY; DRUG THERAPY; EGYPT; EYE MANIFESTATIONS; EYE NEOPLASMS; HISTORY; INFANT; METHOXSALEN; PATHOLOGY; STEROIDS; XERODERMA PIGMENTOSUM

Mesh：

Substances：

Year:  1965        PMID： 14283428     DOI： 10.1111/j.1365-2133.1965.tb14641.x

Source DB:  PubMed          Journal:  Br J Dermatol        ISSN： 0007-0963            Impact factor:   9.302


× No keyword cloud information.
  7 in total

Review 1.  Ophthalmic manifestations and histopathology of xeroderma pigmentosum: two clinicopathological cases and a review of the literature.

Authors:  Hema L Ramkumar; Brian P Brooks; Xiaoguang Cao; Deborah Tamura; John J Digiovanna; Kenneth H Kraemer; Chi-Chao Chan
Journal:  Surv Ophthalmol       Date:  2011 Jul-Aug       Impact factor: 6.048

Review 2.  Management of Extraocular Infections.

Authors:  Srinivasan Muthiah; Naveen Radhakrishnan
Journal:  Indian J Pediatr       Date:  2017-07-14       Impact factor: 1.967

Review 3.  Pterygium as an early indicator of ultraviolet insolation: a hypothesis.

Authors:  M T Coroneo
Journal:  Br J Ophthalmol       Date:  1993-11       Impact factor: 4.638

4.  Ocular melanomas in xeroderma pigmentosum.

Authors:  A J Vivian; D W Ellison; J I McGill
Journal:  Br J Ophthalmol       Date:  1993-09       Impact factor: 4.638

5.  Exuberant epibulbar tumor penetrating into the orbit in xeroderma pigmentosum.

Authors:  M Calugaru; M Barsu
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1992       Impact factor: 3.117

6.  Orbital amelanotic melanoma in xeroderma pigmentosum: a rare association.

Authors:  Syed Ar Rizvi; Abadan K Amitava; Ghazala Mehdi; Rajeev Sharma; Mohammad S Alam
Journal:  Indian J Ophthalmol       Date:  2008 Sep-Oct       Impact factor: 1.848

7.  Ipsilateral presentation of ocular surface squamous neoplasia and conjunctival melanoma in xeroderma pigmentosum: A rare occurrence.

Authors:  Deepanjali Arya; Sima Das; Arpan Gandhi
Journal:  Indian J Ophthalmol       Date:  2019-12       Impact factor: 1.848
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.